Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The PRECISE European initiative for cancer-vulnerability mapping and prediction.

Nature genetics·2026

Same author

Ras-MAPK inhibition induces AXIN1 loss in colorectal cancer by mTOR associated suppression of protein synthesis.

Cell communication and signaling : CCS·2026

Same author

Autoinhibitory feedback preserves intestinal stem cell maintenance and fate commitment.

The EMBO journal·2026

Same author

Monocytes acquire a tumor-associated IL1B program upon encountering patient-derived colon cancer organoids.

Oncoimmunology·2026

Same author

Toll signalling controls intestinal regeneration in Drosophila.

Development (Cambridge, England)·2026

Same author

Improved in vivo gene knockout with high specificity using multiplexed Cas12a sgRNAs.

Nature communications·2026

Search research articles

Related Experiment Video

Updated: Sep 1, 2025

Ubiquitous and Tissue-specific RNA Targeting in Drosophila Melanogaster using CRISPR/CasRx

Ubiquitous and Tissue-specific RNA Targeting in Drosophila Melanogaster using CRISPR/CasRx

Published on: February 5, 2021

Tissue-Specific CRISPR-Cas9 Screening in Drosophila.

Fillip Port¹, Michael Boutros²

¹Division Signaling and Functional Genomics, German Cancer Research Center (DKFZ) and Heidelberg University, Heidelberg, Germany.

Methods in Molecular Biology (Clifton, N.J.)

|August 18, 2022

Summary

This guide details tissue-specific CRISPR screening in Drosophila, offering a powerful new method for functional genomics. It addresses limitations of older genetic screens and provides strategies for accurate gene function discovery.

Keywords:

CRISPR-Cas9 Drosophila Genome editing Screening sgRNA libraries

More Related Videos

An Efficient Strategy for Generating Tissue-specific Binary Transcription Systems in Drosophila by Genome Editing

An Efficient Strategy for Generating Tissue-specific Binary Transcription Systems in Drosophila by Genome Editing

Published on: September 19, 2018

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

Published on: December 11, 2020

Related Experiment Videos

Last Updated: Sep 1, 2025

Ubiquitous and Tissue-specific RNA Targeting in Drosophila Melanogaster using CRISPR/CasRx

Ubiquitous and Tissue-specific RNA Targeting in Drosophila Melanogaster using CRISPR/CasRx

Published on: February 5, 2021

An Efficient Strategy for Generating Tissue-specific Binary Transcription Systems in Drosophila by Genome Editing

An Efficient Strategy for Generating Tissue-specific Binary Transcription Systems in Drosophila by Genome Editing

Published on: September 19, 2018

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

Published on: December 11, 2020

Area of Science:

* Utilizes Drosophila melanogaster as a model organism for fundamental biological research.
* Focuses on functional genomics and gene function discovery in multicellular organisms.

Background:

* Traditional genetic screens (forward and RNAi) have limitations in mutation mapping and gene knockdown efficiency.
* CRISPR-Cas9 technology offers targeted, controllable gene editing for improved genetic screening.
* Drosophila research has historically yielded significant insights into multicellular organism biology.

Purpose of the Study:

* To provide a comprehensive guide for implementing tissue-specific CRISPR screening in Drosophila.
* To detail methods for characterizing CRISPR components and ensuring experimental quality.
* To address potential challenges and offer solutions for accurate results in CRISPR screens.

Main Methods:

* Characterization of Gal4 UAS-Cas9 lines for targeted gene editing.
* Selection and utilization of large-scale sgRNA libraries for comprehensive screening.
* Implementation of quality control measures to validate experimental outcomes.

Main Results:

* CRISPR-Cas9 libraries enable targeted mutations with spatial and temporal control, overcoming limitations of previous methods.
* The guide provides practical steps for researchers to conduct effective tissue-specific CRISPR screens.
* Strategies are discussed for identifying and mitigating false-positive and false-negative results.

Conclusions:

* Conditional CRISPR screening is a transformative approach for in vivo functional genomics.
* This method enhances the understanding of gene function in development, homeostasis, and disease.
* CRISPR screening in Drosophila promises to accelerate biological discovery and knowledge expansion.